Please ensure Javascript is enabled for purposes of website accessibility

3 Fresh IPOs Worth Keeping an Eye On

By Nicholas Rossolillo – Jul 20, 2020 at 11:20AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Coronavirus is accelerating the pivot to digital, helping new digital-native businesses flourish.

In just a few months' time, a lot has changed. Many operations that rely on in-person interaction have been rendered redundant, and with digital businesses picking up the slack, it looks increasingly likely the world will never be the same. 

It's amid this backdrop that a class of new stocks are making their public debut. Three IPOs from mid July I think are worth watching closely are nCino (NASDAQ: NCNO), GoHealth (GOCO), and Digital Media Solutions (DMS).

Big bets on bank updates

Our first subject tripled in its first day of trading. nCino is a software platform that helps typically IT-deprived small- and medium-sized banks and credit unions digitize their operations and replace and/or automate legacy processes. This kind of digital transformation is sweeping the business world, and shelter-in-place orders are making the typical in-person relationship smaller banks used to thrive on especially difficult. It's no wonder then that nCino's IPO was greeted with such gusto.

Adding to the warm reception is that nCino has a similar business model to digital transformation technologist Veeva Systems, which has been getting life science organizations up to speed to great success. Like Veeva, nCino was built using's (CRM) tech platform. Salesforce Ventures -- the company's investment division -- is also one of the primary backers.

I don't think quite the same long-term potential is there for nCino as there has been for Veeva, but it's worth keeping an eye on. The company said its subscription services grew 66% year over year to $34.8 million during the three months ended April 30, 2020, and it reported an adjusted net loss of $4.8 million in that period. As of this writing, nCino has a market cap of $6.6 billion (excluding issuance of more stock in the coming months based on vesting periods and other awards). That means nCino trades for some 37 times revenue at the annualized first-quarter run rate.

It's a rich price tag, and given the stock surged as quickly as it did out the gate, I opted to adopt a wait-and-see strategy with this one. I'm in no rush as Salesforce is a core holding in my portfolio. And as nCino is based on and partially owned by Salesforce, I already have a little indirect exposure to the outfit's success. Nevertheless, I'll be keeping an eye on the fintech firm's progress going forward and may change my mind. 

A laptop, smartphone, and cup of coffee sitting on a table in front of a window.

Image source: Getty Images.

Digitizing the search for insurance 

GoHealth is an insurance plan marketplace that helps match customers with the right health and Medicare supplement policy. The company plays in a crowded sandbox, but it's a big sandbox with more than 10,000 people turning 65 in the U.S. every day and the estimated value of Medicare supplement products alone at $28 billion a year.

GoHealth said its 2019 revenue grew 139% to $539.5 million, and that pace continued in the first quarter as the top line more than doubled to $141.0 million in first quarter. Adjusted EBITDA (earnings before interest, tax, depreciation, and amortization) was $35.2 million in the first quarter, making for a robust 25% adjusted EBITDA margin. The current share price values the insurance firm at roughly $6.7 billion, or 11 times trailing 12-month revenue. It may be surprising, then, that the stock is still trading roughly at its IPO price in the days since it made its debut.

That is likely due to a few factors. The company said it expects second quarter revenue to "only" grow 66% year over year at the midpoint of its guidance. That would indicate a sharp slowdown from the recent past. There's also a complex ownership structure that leaves private equity firm Centerbridge Partners with 13% of total voting power and 48% economic interest in GoHealth. Insurance is also a transactional business, and more predictable software-as-a-service revenue models (like nCino) are all the rage these days. All these factors are worth bearing in mind and following closely as GoHealth begins its journey as a publicly-traded stock.

Nevertheless, I think Medicare insurance plans will be a growth industry for quite some time, and GoHealth's technology has helped it garner significant share of the market. I took a very small position (less than 0.5% of my total portfolio, my typical starter entry point for IPO stocks) and will be keen on seeing how things play out for the rest of 2020 before deciding what to do next. 

Digital ads are soaring

Advertising technology and performance marketing platform Digital Media Solutions just made its debut but via a merger with special purpose acquisition company Leo Holdings (a method employed by a number of other IPOs this year, Nikola Motors being one example).  

Unlike some other well-known adtech outfits, DMS is vertically integrated. It builds long-term relationships directly with organizations and uses various technology platforms to advertise and drive customer conversion for its customers.

Believe it or not, digital marketing exceeded the traditional variety for the first time in 2019. That's changing in dramatic fashion amid the lockdown. I recently spoke with DMS founder and CEO Joe Marinucci, and he said his firm is busier than ever. Estimates put U.S. digital ad spend at some $100 billion in 2019, a number that may be ballooning to $150 billion in 2020. More details will emerge as second quarter earnings season gets underway, but one thing is for sure: Digital promotions just got a massive bump that's unlikely to disappear once the dust settles.  

Specific financials haven't been revealed yet, but upon completion of the merger, DMS had an enterprise value of $757 million, worth 2.2 times 2020 expected revenue (implying expected revenue of about $340 million this year). Sales are expected to grow at a rate of about 18.6% annually through 2021 and EBITDA at a rate of 21.3% per year. That makes DMS the slowest growing firm on this list but also by far the cheapest. Flying under the radar while other tech names are commanding the spotlight, my interest was piqued so I took a similar position like the one outlined above with GoHealth.

The world is quickly changing, and lots of upstart technology-driven businesses are making the most of the opportunity. While uncertainty and economic turmoil reign, I've been adding small-cap stocks to my portfolio that I think have a good shot of turning into big winners over the next decade. These three recent IPOs may fit the bill and are worth a place on your watch list.

Nicholas Rossolillo and his clients own shares of GoHealth, Inc., Nikola,, and Veeva Systems. The Motley Fool owns shares of and recommends and Veeva Systems. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

GoHealth Stock Quote
Digital Media Solutions, Inc. Stock Quote
Digital Media Solutions, Inc.
Salesforce, Inc. Stock Quote
Salesforce, Inc.
Veeva Systems Stock Quote
Veeva Systems
Nikola Corporation Stock Quote
Nikola Corporation

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 10/06/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.